Alimentary Pharmacology and Therapeutics

Aims & Scope

Alimentary Pharmacology & Therapeutics (AP&T) is an international journal of gastroenterology and hepatology.

The journal accepts original papers and systematic reviews concerned with clinical gastroenterology and hepatology.

AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.

Descriptions of adverse effects (but not case reports) and pharmacoepidemiological and toxicological aspects will also be considered.

AP&T only publishes studies performed in human subjects.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	6.7
2024	6.60

SJR (SCImago Journal Rank)

Year	Value
2024	2.892

Quartile

Year	Value
2024	Q1

Journal Rank

Year	Value
2024	768

Journal Citation Indicator

Year	Value
2024	4335

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  Citation: 2426

  Authors: G., A., Z. M.

• Review article: the role of butyrate on colonic function

  Citation: 2202

  Authors: H. M., D., K., S., F. J., R.‐J.

• The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

  Citation: 1312

  Authors: C. Y., J., P. J.

• Current concepts in the management of <i>Helicobacter pylori</i> infection—The Maastricht 2‐2000 Consensus Report

  Citation: 887

  Authors: P., F., C., A. P. S., R., A., D. Y., G.

• Review article: gastrointestinal features in COVID‐19 and the possibility of faecal transmission

  Citation: 645

  Authors: Yuan, Long, Weidong, Yan

• Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis

  Citation: 637

  Authors: A., M. L., A., R., P., M. A. M., J. A.

• Review article: the global emergence of<i>Helicobacter pylori</i>antibiotic resistance

  Citation: 610

  Authors: I., H., V., S., J. Y., S. E., M. A.

• Systematic review with meta‐analysis: the worldwide prevalence of <i>Helicobacter pylori</i> infection

  Citation: 605

  Authors: M., F., V., W. H., R., J., M. H.

• Double‐blind comparison of an oral <i>Escherichia coli</i> preparation and mesalazine in maintaining remission of ulcerative colitis

  Citation: 582

  Authors: W., E., P., B., G., M.

• Increasing prevalence of coeliac disease over time

  Citation: 578

  Authors: S., K., K., K., P., H., O., E., M., A., M.

---